start
collect
druggabl
compound
obtain
pharmacophor
search
perform
similar
search
narrow
scope
dock
studi
templat
molecul
chou
et
al
biochem
biophi
re
commun
mdl
macc
key
use
fingerprint
molecul
tanimoto
coeffici
taken
metric
compar
fingerprint
similar
threshold
set
uniqu
hit
conform
retriev
result
similar
search
autodock
use
carri
molecular
dock
ligand
macromolecular
protein
receptor
three
compound
ie
c
h
n
cl
c
h
n
c
h
n
found
may
promis
candid
investig
main
featur
share
three
potenti
inhibitor
well
inform
involv
side
chain
sar
cov
mpro
may
provid
use
insight
develop
potent
inhibitor
sar
enzym
outbreak
sever
acut
respiratori
syndrom
sar
creat
need
antisar
drug
drosten
et
al
ksiazek
et
al
shortridg
miura
et
al
new
coronaviru
sar
cov
positivesens
singlestrand
rna
viru
gao
et
al
du
et
al
b
found
etiolog
agent
diseas
sar
sar
cov
main
proteinas
mpro
cleav
polyprotein
less
conserv
site
process
initi
enzym
autolyt
cleavag
yang
et
al
releas
polypeptid
mediat
function
requir
sar
viral
replic
transcript
function
import
mpro
viral
life
cycl
make
attract
target
drug
design
sar
yang
et
al
chou
et
al
chou
et
al
anand
et
al
propos
homolog
model
mpro
base
experiment
mpro
structur
human
coronaviru
hcov
porcin
transmiss
gastroenter
viru
tgev
complex
experiment
structur
sar
cov
mpro
first
determin
yang
et
al
provid
sever
crystal
structur
sar
cov
mpro
differ
ph
condit
complex
structur
sar
cov
mpro
ligand
hexapeptidyl
cmk
yang
et
al
experiment
structur
theoret
homolog
structur
sar
cov
mpro
share
mani
structur
similar
catalyt
activ
region
cyshi
cleavag
dyad
yang
et
al
howev
sever
differ
theoret
experiment
structur
exampl
experiment
structur
sar
cov
mpro
dimer
protom
catalyt
activ
protom
b
activ
howev
n
finger
protom
b
plug
activ
cleft
protom
play
import
role
dimer
mainten
activ
form
enzym
yang
et
al
new
find
experiment
structur
sar
cov
mpro
provid
reliabl
basi
inhibitor
design
meanwhil
suggest
suggest
rhinoviru
inhibitor
could
well
serv
start
point
antisar
drug
base
theoret
homolog
model
sar
cov
mpro
chou
et
al
chou
found
fit
problem
bind
pocket
sar
cov
mpro
suggest
deriv
better
start
point
conduct
virtual
screen
sarscov
proteas
base
pharmacophor
point
siroi
et
al
siroi
et
al
found
uniqu
hit
without
volum
constraint
uniqu
hit
volum
constraint
virtual
screen
advantag
less
expans
easier
perform
real
experi
search
lead
compound
ie
calcul
could
perform
compound
yet
purchas
synthes
rayer
therefor
wide
use
find
initi
lead
structur
larg
collect
compound
besid
studi
siroir
et
al
group
also
report
work
screen
inhibitor
sar
xiong
present
studi
mean
systemat
search
molecular
dock
filter
candid
retriev
siroi
et
al
found
interest
result
report
uniqu
hit
found
siroi
et
al
obtain
collect
druggabl
compound
match
pharmacophor
point
satisfi
druggabl
rule
score
valu
narrow
investig
scope
molecular
dock
similar
search
compound
perform
use
chou
et
al
chou
templat
molecul
compound
thu
obtain
place
databas
fingerprint
sheridan
et
al
brown
martin
temper
molecul
compound
databas
calcul
mdl
macc
key
use
fingerprint
molecul
macc
fingerprint
consist
set
indic
show
whether
macc
key
found
present
given
molecul
fingerprint
store
intern
vector
indic
presenc
index
vector
indic
presenc
correspond
substructur
molecul
fingerprint
deriv
chemic
structur
metric
need
compar
fingerprint
common
metric
tanimoto
coeffici
morri
et
al
number
mean
maxim
dissimilar
mean
maxim
similar
similar
threshold
assign
set
uniqu
hit
conform
retriev
outcom
similar
search
autodock
suitabl
softwar
perform
autom
dock
ligand
macromolecular
protein
receptor
individu
compon
program
includ
autotor
autogrid
autodock
autotor
defin
bond
ligand
rotat
affect
degre
freedom
dof
ligand
henc
complex
comput
autogrid
precalcul
threedimension
grid
interact
energi
base
macromolecular
target
use
amber
forc
field
autodock
perform
task
dock
first
ligand
move
randomli
one
six
degre
freedom
name
translat
degre
rotat
degre
energi
new
ligand
state
calcul
energi
new
state
lower
old
state
new
one
automat
accept
next
step
dock
procedur
use
chou
carlacci
chou
sinc
ligand
peptid
gasteig
charg
assign
nonpolar
hydrogen
merg
rigid
root
ligand
defin
automat
instead
pick
manual
amid
bond
made
nonrotat
experiment
structur
sar
cov
mpro
extract
rcsb
protein
data
bank
whose
pdb
code
mpro
dimer
protom
catalyt
activ
protom
b
accordingli
protom
b
remov
kollman
charg
ad
atom
remain
protom
yang
et
al
gal
search
algorithm
larmarckian
genet
algorithm
chosen
search
best
conform
dock
process
maximum
conform
consid
compound
default
conform
initi
posit
ligand
center
box
orient
randomli
paramet
set
use
softwar
adt
autodock
tool
kit
pc
associ
autodock
calcul
autogrid
autodock
perform
sun
enterpris
server
cpu
memori
two
kind
free
energi
output
autodock
one
predict
bind
free
energi
includ
intermolecular
energi
torsion
free
energi
dock
energi
includ
intermolecular
intramolecular
energi
former
report
end
dock
oper
latter
use
select
better
individu
popul
dock
run
morri
et
al
use
energi
respect
criterion
rank
moreov
factor
need
examin
check
screen
result
ligand
locat
hydrophob
effect
steric
complementar
size
ligand
therefor
rank
conform
accord
low
energi
ligand
care
check
accord
aforement
factor
well
furthermor
intermolecular
hydrogen
bond
electrostat
interact
whose
effect
alreadi
count
bind
energi
also
investig
order
find
use
inform
drug
design
shown
rank
tabl
dock
result
rank
accord
ascent
dock
energi
conform
ligand
investig
found
close
view
compound
dock
mpro
conform
outsid
activ
region
concern
even
far
away
pocket
check
low
dock
energi
conform
ligand
ligand
found
mani
buri
protein
expos
outsid
molecul
larg
size
stay
comfort
incommodi
pocket
contrast
rank
dock
result
accord
bind
free
energi
includ
torsion
term
shown
rank
tabl
found
ligand
interact
quit
well
receptor
pocket
top
ligand
rank
smaller
size
top
ligand
rank
exampl
given
fig
show
complex
dock
ligand
sar
mpro
comparison
result
rank
suggest
bind
free
energi
reliabl
criterion
virtual
screen
via
molecular
dock
seem
torsion
term
ie
unfavour
entropi
ligand
bind
play
import
role
ligandreceptor
interact
especi
larges
ligand
suffer
loss
torsion
freedom
upon
bind
volum
ligand
allow
get
pocket
correspond
interact
energi
would
meaningless
recurr
ident
conform
one
ligand
mean
fit
well
pocket
like
good
inhibitor
candid
output
dlg
file
dock
run
cluster
conform
sort
accord
rmd
valu
found
cluster
tabl
mark
plot
one
fig
except
ligand
render
purpl
ligand
blue
differ
increas
right
end
molecul
might
caus
fact
interact
less
specif
two
conform
ligand
cluster
rmd
toler
set
conform
ident
two
shown
fig
firstrank
fig
hydrogen
bond
ligand
involv
residu
sar
cov
mpro
purpl
dot
denot
hydrogen
bond
denot
stand
involv
residu
respect
atom
shown
stick
draw
color
atom
type
hydrogen
color
white
carbon
gray
oxygen
red
nitrogen
blue
chlorin
green
sulfur
yellow
mpro
show
steric
hindranc
connolli
surfac
color
blue
ligand
color
atom
type
shown
atom
ligand
penetr
molecular
surfac
mpro
caus
strong
steric
hindranc
note
surfac
atom
scalar
surfac
differ
solvent
exclud
surfac
ligand
accord
order
rank
probabl
potent
inhibitor
also
comparison
bind
structur
among
best
conform
ligand
top
three
ligand
top
two
ligand
top
one
ligand
indic
quit
similar
especi
fiveatom
ring
link
alkyl
shown
fig
find
may
also
use
structurebas
drug
design
hydrogen
bond
make
import
contribut
interact
ligand
receptor
observ
sever
conform
ligand
whose
complex
mpro
visual
examin
best
four
conform
complex
form
ligand
mpro
four
three
four
two
hydrogen
bond
form
respect
four
hydrogen
bond
involv
two
involv
two
involv
one
involv
exampl
hydrogen
bond
ligand
particip
residu
mpro
shown
fig
also
hydrogen
bond
form
ligand
mpro
respect
occur
five
time
twice
frequenc
residu
occurr
format
hydrogen
bond
play
import
role
may
due
polar
hydrogen
imidazol
ring
perfect
hydrogen
bond
donor
also
take
part
hydrogen
bond
rel
high
frequenc
inform
could
help
drug
design
potenti
drug
interact
well
residu
especi
great
concern
antisar
drug
design
believ
one
catalyt
dyad
du
et
al
b
therefor
import
imidazol
ring
lock
catalyt
function
depress
found
hydrogen
bond
nearbi
residu
receptor
chou
et
al
among
ligand
screen
found
anyon
form
hydrogen
bond
comparison
aforement
activ
site
residu
involv
hydrogen
bond
set
nonetheless
quit
close
residu
activ
site
besid
hydrogen
bond
contribut
total
gibb
free
energi
induc
bond
desolv
hydrophob
interact
electrostat
interact
hydrogen
bond
may
act
anchor
determin
posit
ligand
bind
pocket
thu
facilit
hydrophob
interact
electrostat
interact
output
autodock
calcul
potenti
energi
van
der
waal
interact
electrostat
interact
report
separ
select
group
molecul
number
atom
obviou
differ
energi
whose
van
der
waal
potenti
electrostat
potenti
ad
group
electrostat
interact
energi
vari
one
anoth
small
compar
total
free
energi
calcul
van
der
waal
energi
play
main
part
total
energi
also
factor
respons
remain
differ
energi
vari
kalmol
desolv
term
emerg
possibl
includ
autodock
score
function
torsion
free
energi
depend
number
torsion
molecul
molecul
align
pocket
solventexclud
surfac
ligandreceptor
complex
examin
shown
fig
hydrophob
area
ligand
mpro
complement
respect
see
fig
thu
entropi
desolv
upon
bind
increas
depart
water
molecul
molecular
surfac
bind
take
place
vacuum
solvat
water
deepli
involv
play
import
role
studi
hydrophob
interact
relev
proteinfold
problem
anfinsen
hydrophob
tanford
model
fold
protein
hydrophob
amino
acid
side
chain
interior
form
oil
drop
impli
protein
fold
hydrophob
side
chain
preferenti
buri
away
extern
solvent
studi
process
ligandreceptor
surfac
buri
like
case
protein
fold
ration
drug
design
critic
identifi
hydrophob
group
ligand
receptor
ensur
face
upon
bind
discuss
thermodynam
ligandreceptor
bind
moreov
side
bind
kinet
also
taken
consider
kinet
bind
process
mainli
determin
steric
complementar
vaidyanathan
et
al
chou
zhou
chou
chou
chou
jiang
zhou
zhong
steric
complementar
make
caviti
site
access
ligand
connolli
surfac
ligandsar
mpro
examin
shown
fig
ligand
form
four
hydrogen
bond
sar
mpro
fulli
occupi
caviti
lie
comfort
receptor
pocket
give
evid
key
role
steric
complementar
poor
steric
complementar
steric
hindranc
shown
fig
although
three
hydrogen
bond
complex
gibb
free
energi
still
kalmol
higher
ligand
mean
steric
complementar
suppos
respons
micromechan
interlock
molecular
level
suggest
vaidyanathan
et
al
primari
drive
forc
mechan
interlock
steric
complementar
ligand
collagen
receptor
site
mechan
interlock
facilit
steric
complementar
bind
interact
may
also
occur
therefor
drug
design
modif
lead
compound
must
first
take
steric
configur
account
three
compound
c
h
n
cl
c
h
n
c
h
n
ie
ligand
tabl
may
promis
candid
modif
structurebas
drug
design
studi
current
way
laboratori
